Beta Drugs Limited — Call Transcript 2023

Apr 26, 2023

BE DRUGS LIMITED

BDL/PKL/SECl2023 25th April, 2023

National Stock Exchange of India Ltd. Exchange Plaza, 5th Floor Plot no. C/1, G Block Bandra-Kurla Complex, Bandra (E) Mumbai - 400 051.

SYMBOL.BETA

Sub:- Earnings conference callto discuss Operational and Financial performance.

Dear Sir,

pursuant to Regulation 30(5) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 20L5, we hereby inform you that the Management of our Company will be hosting a Earnings conference call to discuss Operational and Financial performance on Tuesday, 9th May,2023 at 4:00 P.M..(lST). We are enclosing herewith the invitation to the conference call for reference.

Thanking You Your's faithfully

CIN No. : L2423OHP2005PLC028969

Admin. Office : SCO 184, Sector-S, Panchkula-134114 Haryana (lNDlA) Phone: +91-172-2585481482483 Registered Office & Works: Vill. Nandpur, Lodhimajra Road, Tehsil. : Baddi, Distt. Solan, H.P. Phone No. : 01795-236196

PRIVATE CLIENT GROUP

Conference Call Invitation

PhillipCapital (India) Private Limited cordially invites you to participate in

H2 & FY23 Earnings conference call to discuss operational and financial performance.

Speakers Mr. Rahul Batra – Chairman & Managing Director Mr. Nipun Arora – Chief Financial Officer Mr. Ashutosh Shukla – Director (Sales & Marketing)

Tuesday – 9 th May, 2023 @ 04:00 PM IST 06:30 PM Singapore & HK / 11.30 AM UK

Call Leader Mr. Sagar Shah / Mr. Apurva Shah

Pre-register to avoid wait time, join with DiamondPass. Click here here to register

Dial-In-Numbers

Primary Number: +91 22 6280 1143 / +91 22 7115 8044

The numbers listed above are universally accessible from all networks and all countries.

Toll Free Number: USA: 18667462133 / UK: 08081011573 / Singapore: 8001012045 / Hong Kong: 800964448

#PhillipCapital (India) Private Limited remains committed to adhere to all regulatory guidelines and follow the best governance and transparency practices. Therefore:

• The proceedings of this call will be recorded.
• The list and full details of participants on the call will be shared by us with the corporate. Participants are expected to provide true and legitimate details.
• All necessary disclosures on Stock Exchanges (including call invite intimation, recording details & call transcript) is expected to be complied by the respective corporate.